A Phase II trial of BEN-8744 for treatment of ulcerative colitis
Latest Information Update: 27 Apr 2022
At a glance
- Drugs BEN-8744 (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors BenevolentAI
Most Recent Events
- 27 Apr 2022 New trial record